DIHYDROERGOTAMINE DRY POWER FORMULATIONS AND METHODS OF USE

The present disclosure relates to dry powder formulations comprising respirable dry particles that comprise 1) dihydroergotamine (DHE) or a salt, hydrate, or polymorph thereof, 2) a monovalent metal cation salt, and 3) one or more excipients; and also relates to methods of using the dry powder for t...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: HANSON, Dayna, STOLZ, Eric, CURRAN, Aidan, GONZALEZ NELSON, Aaron, PERRY, Jason, BERGSON, Hillary
Format: Patent
Sprache:eng ; fre
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator HANSON, Dayna
STOLZ, Eric
CURRAN, Aidan
GONZALEZ NELSON, Aaron
PERRY, Jason
BERGSON, Hillary
description The present disclosure relates to dry powder formulations comprising respirable dry particles that comprise 1) dihydroergotamine (DHE) or a salt, hydrate, or polymorph thereof, 2) a monovalent metal cation salt, and 3) one or more excipients; and also relates to methods of using the dry powder for the treatment of a migraine, headache, or a symptom thereof, methods of making the dry powder, and receptacles and devices containing the dry powder. La présente divulgation concerne des formulations de poudre sèche comprenant des particules sèches respirables qui comprennent 1) de la dihydroergotamine (DHE) ou un sel, un hydrate, ou un polymorphe de celle-ci, 2) un sel de cation métallique monovalent, et 3) un ou plusieurs excipients ; et qui concerne également des procédés d'utilisation de la poudre sèche pour le traitement d'une migraine, d'un mal de tête, ou d'un symptôme de ceux-ci, des procédés de fabrication de la poudre sèche, et des réceptacles et des dispositifs contenant la poudre sèche.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2022187222A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2022187222A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2022187222A13</originalsourceid><addsrcrecordid>eNrjZLB28fSIdAnydw1y9w9x9PX0c1VwCYpUCPAPdw1ScPMP8g31cQzx9PcLVnD0c1HwdQ3x8HcJVvB3UwgNduVhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYnJqXmpJfHh_kYGRkaGFuZGRkaOhsbEqQIAqTkqcA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>DIHYDROERGOTAMINE DRY POWER FORMULATIONS AND METHODS OF USE</title><source>esp@cenet</source><creator>HANSON, Dayna ; STOLZ, Eric ; CURRAN, Aidan ; GONZALEZ NELSON, Aaron ; PERRY, Jason ; BERGSON, Hillary</creator><creatorcontrib>HANSON, Dayna ; STOLZ, Eric ; CURRAN, Aidan ; GONZALEZ NELSON, Aaron ; PERRY, Jason ; BERGSON, Hillary</creatorcontrib><description>The present disclosure relates to dry powder formulations comprising respirable dry particles that comprise 1) dihydroergotamine (DHE) or a salt, hydrate, or polymorph thereof, 2) a monovalent metal cation salt, and 3) one or more excipients; and also relates to methods of using the dry powder for the treatment of a migraine, headache, or a symptom thereof, methods of making the dry powder, and receptacles and devices containing the dry powder. La présente divulgation concerne des formulations de poudre sèche comprenant des particules sèches respirables qui comprennent 1) de la dihydroergotamine (DHE) ou un sel, un hydrate, ou un polymorphe de celle-ci, 2) un sel de cation métallique monovalent, et 3) un ou plusieurs excipients ; et qui concerne également des procédés d'utilisation de la poudre sèche pour le traitement d'une migraine, d'un mal de tête, ou d'un symptôme de ceux-ci, des procédés de fabrication de la poudre sèche, et des réceptacles et des dispositifs contenant la poudre sèche.</description><language>eng ; fre</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20220909&amp;DB=EPODOC&amp;CC=WO&amp;NR=2022187222A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20220909&amp;DB=EPODOC&amp;CC=WO&amp;NR=2022187222A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>HANSON, Dayna</creatorcontrib><creatorcontrib>STOLZ, Eric</creatorcontrib><creatorcontrib>CURRAN, Aidan</creatorcontrib><creatorcontrib>GONZALEZ NELSON, Aaron</creatorcontrib><creatorcontrib>PERRY, Jason</creatorcontrib><creatorcontrib>BERGSON, Hillary</creatorcontrib><title>DIHYDROERGOTAMINE DRY POWER FORMULATIONS AND METHODS OF USE</title><description>The present disclosure relates to dry powder formulations comprising respirable dry particles that comprise 1) dihydroergotamine (DHE) or a salt, hydrate, or polymorph thereof, 2) a monovalent metal cation salt, and 3) one or more excipients; and also relates to methods of using the dry powder for the treatment of a migraine, headache, or a symptom thereof, methods of making the dry powder, and receptacles and devices containing the dry powder. La présente divulgation concerne des formulations de poudre sèche comprenant des particules sèches respirables qui comprennent 1) de la dihydroergotamine (DHE) ou un sel, un hydrate, ou un polymorphe de celle-ci, 2) un sel de cation métallique monovalent, et 3) un ou plusieurs excipients ; et qui concerne également des procédés d'utilisation de la poudre sèche pour le traitement d'une migraine, d'un mal de tête, ou d'un symptôme de ceux-ci, des procédés de fabrication de la poudre sèche, et des réceptacles et des dispositifs contenant la poudre sèche.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLB28fSIdAnydw1y9w9x9PX0c1VwCYpUCPAPdw1ScPMP8g31cQzx9PcLVnD0c1HwdQ3x8HcJVvB3UwgNduVhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYnJqXmpJfHh_kYGRkaGFuZGRkaOhsbEqQIAqTkqcA</recordid><startdate>20220909</startdate><enddate>20220909</enddate><creator>HANSON, Dayna</creator><creator>STOLZ, Eric</creator><creator>CURRAN, Aidan</creator><creator>GONZALEZ NELSON, Aaron</creator><creator>PERRY, Jason</creator><creator>BERGSON, Hillary</creator><scope>EVB</scope></search><sort><creationdate>20220909</creationdate><title>DIHYDROERGOTAMINE DRY POWER FORMULATIONS AND METHODS OF USE</title><author>HANSON, Dayna ; STOLZ, Eric ; CURRAN, Aidan ; GONZALEZ NELSON, Aaron ; PERRY, Jason ; BERGSON, Hillary</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2022187222A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2022</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>HANSON, Dayna</creatorcontrib><creatorcontrib>STOLZ, Eric</creatorcontrib><creatorcontrib>CURRAN, Aidan</creatorcontrib><creatorcontrib>GONZALEZ NELSON, Aaron</creatorcontrib><creatorcontrib>PERRY, Jason</creatorcontrib><creatorcontrib>BERGSON, Hillary</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>HANSON, Dayna</au><au>STOLZ, Eric</au><au>CURRAN, Aidan</au><au>GONZALEZ NELSON, Aaron</au><au>PERRY, Jason</au><au>BERGSON, Hillary</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>DIHYDROERGOTAMINE DRY POWER FORMULATIONS AND METHODS OF USE</title><date>2022-09-09</date><risdate>2022</risdate><abstract>The present disclosure relates to dry powder formulations comprising respirable dry particles that comprise 1) dihydroergotamine (DHE) or a salt, hydrate, or polymorph thereof, 2) a monovalent metal cation salt, and 3) one or more excipients; and also relates to methods of using the dry powder for the treatment of a migraine, headache, or a symptom thereof, methods of making the dry powder, and receptacles and devices containing the dry powder. La présente divulgation concerne des formulations de poudre sèche comprenant des particules sèches respirables qui comprennent 1) de la dihydroergotamine (DHE) ou un sel, un hydrate, ou un polymorphe de celle-ci, 2) un sel de cation métallique monovalent, et 3) un ou plusieurs excipients ; et qui concerne également des procédés d'utilisation de la poudre sèche pour le traitement d'une migraine, d'un mal de tête, ou d'un symptôme de ceux-ci, des procédés de fabrication de la poudre sèche, et des réceptacles et des dispositifs contenant la poudre sèche.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre
recordid cdi_epo_espacenet_WO2022187222A1
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title DIHYDROERGOTAMINE DRY POWER FORMULATIONS AND METHODS OF USE
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T04%3A14%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=HANSON,%20Dayna&rft.date=2022-09-09&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2022187222A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true